Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia

Experimental Neurology

Volumn 204, Issue 2, 2007, Pages 748-758

  Kim, Do Hoon ^a   Li, Hua ^a   Yoo, Ki Yeon ^a   Lee, Bong Hee ^b   Hwang, In Koo ^a   Won, Moo Ho ^a  

^a Hallym University   (South Korea)

^b Institute of Medical Science   (South Korea)

Author keywords

Antioxidative enzymes; Brain derived neurotrophic factor; Fluoxetine; Hippocampal CA1 pyramidal cells; Neuroprotection; Spontaneous motor activity; Transient forebrain ischemia

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FLUOXETINE; GLUTATHIONE PEROXIDASE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; ENZYME ACTIVITY; FOREBRAIN; GERBIL; HISTOLOGY; IMMUNOREACTIVITY; MOTOR ACTIVITY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; GENE EXPRESSION REGULATION; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 33947678712     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.01.008     Document Type: Article

References (47)

1. Amano M., Hasegawa M., Hasegawa T., and Nabeshima T. Characteristics of transient cerebral ischemia-induced deficits on various learning and memory tasks in male Mongolian gerbils. Jpn. J. Pharmacol. 63 (1993) 469-477
2. Andersen M.B., and Sams-Dodd F. Impairment of working memory in the T-maze after transient global cerebral ischemia in the Mongolian gerbil. Behav. Brain Res. 91 (1998) 15-22
3. Andersen M.B., Zimmer J., and Sams-Dodd F. Postischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons. Behav. Neurosci. 111 (1997) 1205-1216
4. Araki H., Hino N., Karasawa Y., Kawasaki H., and Gomita Y. Effect of dopamine blockers on cerebral ischemia-induced hyperactivity in gerbils. Physiol. Behav. 66 (1999) 263-268
5. Araki H., Yamamoto T., Kobayashi Y., Futagami K., Kawasaki H., and Gomita Y. Effect of methamphetamine and imipramine on cerebral ischemia-induced hyperactivity in Mongolian gerbils. Jpn. J. Pharmacol. 88 (2002) 293-299
6. Babcock A.M., Baker D.A., and Lovec R. Locomotor activity in the ischemic gerbil. Brain Res. 625 (1993) 351-354
7. Beck T., Lindholm D., Castren E., and Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14 (1994) 689-692
8. Calabresi P., Stefani A., Marfia G.A., Hainsworth A.H., Centonze D., Saulle E., Spadoni F., Leach M.J., Giacomini P., and Bernardi G. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. Exp. Neurol. 162 (2000) 171-179
9. 2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol. Psychiatry 54 (2003) 59-69
10. Chandler M.J., DeLeo J., and Carney J.M. An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J. Pharmacol. Methods 14 (1985) 137-146
11. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
12. Cheng B., and Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640 (1994) 56-67
13. Colbourne F., and Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J. Neurosci. 15 (1995) 7250-7260
14. Coppell A.L., Pei Q., and Zetterstrom T.S.C. Biphasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2000) 903-910
15. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., and Zetterstrom T.S. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
16. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol. Psychiatry 44 (1998) 324-335
17. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
18. Gabaizadeh R., Staecker H., Liu W., and Van De Water T.R. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Brain Res. Mol. Brain Res. 50 (1997) 71-78
19. Gainotti G., Antonucci G., Marra C., and Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J. Neurol., Neurosurg. Psychiatry 71 (2001) 258-261
20. Gerhardt, S.C., Boast, C.A., 1988. Motor activity changes following cerebral ischemia in gerbils are correlated with the degree of neuronal degeneration in hippocampus. Behav. Neurosci. 102, 301-303, 328.
21. Hains B.C., Everhart A.W., Fullwood S.D., and Hulsebosch C.E. Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp. Neurol. 175 (2002) 347-362
22. Haque M.E., Tanaka K., and Ogawa N. Relationship between locomotor activity and monoamines following single and double transient forebrain ischemia in gerbils. Neurochem. Res. 26 (2001) 401-406
23. Haynes L.E., Barber D., and Mitchell I.J. Chronic antidepressant medication attenuates dexamethasone-induced neuronal death and sublethal neuronal damage in the hippocampus and striatum. Brain Res. 1026 (2004) 157-167
24. Himeda T., Tounai H., Hayakawa N., and Araki T. Postischemic alterations of BDNF, NGF, HSP 70 and ubiquitin immunoreactivity in the gerbil hippocampus: pharmacological approach. Cell. Mol. Neurobiol. (2006) (Jun 30 Electronic publication ahead of print)
25. Hwang I.K., Eum W.S., Yoo K.Y., Cho J.H., Kim D.W., Choi S.H., Kang T.C., Kwon O.S., Kang J.H., Choi S.Y., and Won M.H. Copper chaperone for Cu,Zn-SOD supplement potentiates the Cu, Zn-SOD function of neuroprotective effects against ischemic neuronal damage in the gerbil hippocampus. Free Radical Biol. Med. 39 (2005) 392-402
26. Hwang I.K., Yoo K.Y., Kim Y.S., Jung B.K., Li H., Kim D.H., Kang T.C., Shin H.C., and Won M.H. The immunoreactivity and activity of adenylate cyclase type I are changed in the hippocampal CA1 region after transient forebrain ischemia in gerbils. J. Neurol. Sci. 240 (2006) 93-98
27. 1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp. Neurol. 184 (2003) 964-972
28. Jolkkonen J., Puurunen K., Rantakomi S., Sirvio J., Haapalinna A., and Sivenius J. Effects of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats. Restor. Neurol. Neurosci. 17 (2000) 211-216
29. Karasawa Y., Araki H., and Otomo S. Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils. Stroke 25 (1994) 645-650
30. Kato H., Kogure K., and Nakano S. Neuronal damage following repeated brief ischemia in the gerbil. Brain Res. 479 (1989) 366-370
31. Kokaia Z., Othberg A., Kokaia M., and Lindvall O. BDNF makes cultured dentate granule cells more resistant to hypoglycaemic damage. NeuroReport 5 (1994) 1241-1244
32. Kolla N., Wei Z., Richardson J.S., and Li X.M. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J. Psychiatry Neurosci. 30 (2005) 196-201
33. Kuroiwa T., Bonnekoh P., and Hossmann K.A. Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils. Neurosci. Lett. 122 (1991) 141-144
34. Lee H.J., Kim J.W., Yim S.V., Kim M.J., Kim S.A., Kim Y.J., Kim C.J., and Chung J.H. Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol. Psychiatry. 6 610 (2001) 725-728
35. Lee T.H., Kato H., Chen S.T., Kogure K., and Itoyama Y. Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons. NeuroReport 13 (2002) 2271-2275
36. Mileson B.E., and Schwartz R.D. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett. 128 (1991) 71-76
37. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J. Neurosci. 15 (1995) 7539-7547
38. Nurse S., and Corbett D. Direct measurement of brain temperature during and after intraischemic hypothermia: correlation with behavioral, physiological, and histological endpoints. J. Neurosci. 14 (1994) 7726-7734
39. Pariente J., Loubinoux I., Carel C., Albucher J.F., Leger A., Manelfe C., Rascol O., and Chollet F. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 50 (2001) 718-729
40. Primeau F. Post-stroke depression: a critical review of the literature. Can. J. Psychiatry 33 (1988) 757-765
41. Schwartz E.D., Shumsky J.S., Wehrli S., Tessler A., Murray M., and Hackney D.B. Ex vivo MR determined apparent diffusion coefficients correlate with motor recovery mediated by intraspinal transplants of fibroblasts genetically modified to express BDNF. Exp. Neurol. 182 (2003) 49-63
42. Vellucci S.V., Parrott R.F., and Mimmack M.L. Down-regulation of BDNF mRNA, with no effect on trkB or glucocorticoid receptor m RNAs, in the porcine hippocampus after acute dexamethasone treatment. Res. Vet. Sci. 70 (2001) 157-162
43. Wang D., and Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res. 533 (1990) 78-82
44. Wengenack T.M., Curran G.L., and Poduslo J.F. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res. 754 (1997) 46-54
45. Wiart L., Petit H., Joseph P.A., Mazaux J.M., and Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31 (2000) 1829-1832
46. Yamamoto T., Araki H., Futagami K., Kawasaki H., and Gomita Y. Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils. Acta Med. Okayama 55 (2001) 277-282
47. Zhao C.S., Puurunen K., Schallert T., Sivenius J., and Jolkkonen J. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav. Brain Res. 158 (2005) 211-220